Potluck community medicine
نویسندگان
چکیده
منابع مشابه
The Potluck Problem
JEL classification codes: C51 Model construction and estimation C62 Existence and stability conditions of equilibrium D84 Expectations Speculations This paper proposes the Potluck Problem as a model for the behavior of independent producers and consumers under standardeconomicassumptions, as a problemof resourceallocation inamulti-agent system inwhich there is no explicit communication among th...
متن کاملA POTluck of peptide transporters.
The uptake of diet-derived peptides is mediated by the conserved proton-dependent oligopeptide transporter (POT) family. Crystal structures of bacterial transporters in the inward-open conformation and in an occluded conformation published in The EMBO Journal provide structural insight into the proton-driven peptide transport cycle. Lipid bilayers are generally not permeable to amino acids, pep...
متن کاملCommunity medicine.
Background: Road crash injury is largely preventable and predictable; it is a human-made problem amenable to rational analysis and countermeasures. All the studies on Road Traffic accidents either use number of accidents or victims according to availability of accident data. Studies combining these two types of data to identify hazardous locations are a rarity. In this study data on both, the n...
متن کاملCommunity genetics and community medicine.
In the decades to come, molecular genetic insights and techniques will have great influence on prevention and health care. Health care providers should anticipate important new developments rather than just wait and see. For community doctors, who can impossibly oversee all relevant developments in sufficient detail, close communication with the community and clinical genetic specialists is nec...
متن کاملJanus kinase inhibitors: jackpot or potluck?
The reports of a unique mutation in the Janus kinase-2 gene (JAK2) in polycythemia vera by several independent groups in 2005 quickly spurred the development of the Janus kinase inhibitors. In one of the great victories of translational research in recent times, the first smallmolecule Janus kinase inhibitor ruxolitinib entered a phase I trial in 2007. With the approval of ruxolitinib by the US...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Academic Medicine
سال: 1979
ISSN: 1040-2446
DOI: 10.1097/00001888-197912000-00010